TGM2 Human, Sf9

SKU:BHZ11000510
Catalog / Quick links
    Overview
    Click light‑blue chips for details
    Tissue Transglutaminase Human Recombinant, Sf9 Celiac disease is an enteropathy that is characterized by intestinal lesions of variable severity. Tissue-type transglutaminase (tTG) is believed to be the predominant autoantigen for celiac disease and the corresponding autoantibodies show higher sensitivity and specificity than anti-gliadin antibodies. Highly pure recombinant human tTG is now available to replace the traditionally used tTG fraction from guinea pig.Tissue-type transglutaminase antigens have been specifically modified for improved handling: exchange of an active site amino acid eliminates the protein cross-linking activity of the enzyme, while maintaining the native three-dimensional structure and the enzyme's secondary GTPase activity. This engineering assures reproducible properties of the antigen preparations through the absence of variable and ill-defined covalent aggregates of tTG antigen and host cell proteins.
    Enzyme Type TGM2
    Species Human
    Form Liquid
    Expression System Sf9 Insect Cells
    Purity 95%
    Gene Symbol TGM2 Sf9
    Source Sf9 insect cells.
    Available Options
    5µg | 20µg | 1mg
    Options selector
    Catalog no. Size
    ENZ-303-5µg 5µg
    ENZ-303-20µg 20µg
    ENZ-303-1mg 1mg
    Field Specification
    Enzyme Type
    • TGM2
    Expression System
    • Sf9 Insect Cells
    Form Liquid
    Formulation TGM2 is supplied in 16mM HEPES buffer pH-8.0, 320mM NaCl and 20% glycerol.
    Product Type
    • Enzyme
    Purity 95%
    Source Sf9 insect cells.
    Species Human
    Storage Store at 4°C if entire vial will be used within 2-4weeks. Store, frozen at -20°C for longer periods of time. Avoid multiple freeze-thaw cycles.
    Target TGM2 Sf9

    Product Description

    Tissue Transglutaminase Human Recombinant, Sf9

    Overview

    Celiac disease is an enteropathy that is characterized by intestinal lesions of variable severity. Tissue-type transglutaminase (tTG) is believed to be the predominant autoantigen for celiac disease and the corresponding autoantibodies show higher sensitivity and specificity than anti-gliadin antibodies. Highly pure recombinant human tTG is now available to replace the traditionally used tTG fraction from guinea pig.Tissue-type transglutaminase antigens have been specifically modified for improved handling: exchange of an active site amino acid eliminates the protein cross-linking activity of the enzyme, while maintaining the native three-dimensional structure and the enzyme's secondary GTPase activity. This engineering assures reproducible properties of the antigen preparations through the absence of variable and ill-defined covalent aggregates of tTG antigen and host cell proteins.

    Specifications

    Purity Greater than 95% as determined by SDS-PAGE.
    Formulation TGM2 is supplied in 16mM HEPES buffer pH-8.0, 320mM NaCl and 20% glycerol.
    Storage Store at 4°C if entire vial will be used within 2-4weeks. Store, frozen at -20°C for longer periods of time. Avoid multiple freeze-thaw cycles.
    Expression System Sf9 insect cells.

    Get a Quote

    Please use this form for bulk quantity requests or customized products.

    Contact Information

    Product Information

    Supplier Ads Slides show

    Add dynamic ads with slider